Case report: Percutaneous adrenal arterial embolization cures resistant hypertension

被引:7
作者
Zhou, Yaqiong [1 ,2 ,3 ]
Wang, Dan [1 ,2 ,3 ]
Liu, Qiting [1 ,2 ,3 ]
Hou, Jixin [1 ,2 ,3 ]
Wang, Peijian [1 ,2 ,3 ]
机构
[1] Chengdu Med Coll, Clin Med Coll, Dept Cardiol, Chengdu, Peoples R China
[2] ChengduMed Coll, Affiliated Hosp 1, Chengdu, Peoples R China
[3] Sichuan Higher Educ Inst, Key Lab Aging & Vasc Homeostasis, Chengdu, Peoples R China
来源
FRONTIERS IN CARDIOVASCULAR MEDICINE | 2022年 / 9卷
基金
中国国家自然科学基金;
关键词
primary aldosteronism; hypertension; adrenal arterial embolization; ablation; case report; TREATED PRIMARY ALDOSTERONISM; BLOOD-PRESSURE; OUTCOMES; COMPLICATIONS; DIAGNOSIS; MORTALITY; CONSENSUS; SOCIETY;
D O I
10.3389/fcvm.2022.1013426
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundPrimary aldosteronism is a common cause of resistant hypertension. Patients with primary aldosteronism due to aldosterone-producing adenoma are generally treated with unilateral adrenalectomy or medical therapy. Superselective adrenal arterial embolization is an alternative treatment for patients with unilateral primary aldosteronism. Case summaryWe present a 39-year-old male patient with a 5-year history of primary aldosteronism and secondary hypertension. The patient refused adrenalectomy while accepted pharmacotherapy. Despite taking adequate dose of spironolactone, the patient experienced repeatedly muscle weakness due to hypokalemia and had poor blood pressure control with left ventricular hypertrophy and renal dysfunction. Aldosterone-producing adenoma in the left adrenal gland was confirmed by computerized tomography and adrenal venous sampling. The left middle adrenal artery, which was confirmed to provide the main arterial supply to the aldosterone-producing adenoma, was embolized by injecting 2 ml ethanol. The embolization normalized his blood pressure for up to 3 months and reversed left ventricular hypertrophy. ConclusionSuperselective adrenal arterial embolization could be an alternative treatment for patients with aldosterone-producing adenoma who refuse adrenalectomy.
引用
收藏
页数:6
相关论文
共 50 条
  • [1] A controlled trial of percutaneous adrenal arterial embolization for hypertension in patients with idiopathic hyperaldosteronism
    Zhou, Yaqiong
    Wang, Xinquan
    Hou, Jixin
    Wan, Jindong
    Yang, Yi
    Liu, Sen
    Luo, Tao
    Liu, Qiting
    Xue, Qiang
    Wang, Peijian
    HYPERTENSION RESEARCH, 2024, 47 (02) : 311 - 321
  • [2] A controlled trial of percutaneous adrenal arterial embolization for hypertension in patients with idiopathic hyperaldosteronism
    Yaqiong Zhou
    Xinquan Wang
    Jixin Hou
    Jindong Wan
    Yi Yang
    Sen Liu
    Tao Luo
    Qiting Liu
    Qiang Xue
    Peijian Wang
    Hypertension Research, 2024, 47 : 311 - 321
  • [3] The Long-term Effect of Adrenal Arterial Embolization for Unilateral Primary Aldosteronism on Cardiorenovascular Protection, Blood Pressure, and the Endocrinological Profile
    Kometani, Mitsuhiro
    Yoneda, Takashi
    Demura, Masashi
    Karashima, Shigehiro
    Mori, Shunsuke
    Oe, Masashi
    Sawamura, Toshitaka
    Okuda, Rika
    Yamagishi, Masakazu
    Takeda, Yoshiyu
    INTERNAL MEDICINE, 2016, 55 (07) : 769 - 773
  • [4] Adrenal arterial embolization: a possible new treatment for patients with primary aldosteronism
    Yokota, Kenichi
    HYPERTENSION RESEARCH, 2024, 47 (02) : 358 - 360
  • [5] A case of primary aldosteronism with resistant hypertension successfully treated by unilateral adrenalectomy after unsuccessful classification of subtype in adrenal venous sampling
    Nakamaru, Ryo
    Yamamoto, Koichi
    Nozato, Satoko
    Hongyo, Kazuhiro
    Nagasawa, Motonori
    Hagiya, Hideharu
    Nakagami, Futoshi
    Akasaka, Hiroshi
    Kurinami, Hitomi
    Takami, Yoichi
    Takeya, Yasushi
    Sugimoto, Ken
    Ujike, Takeshi
    Uemura, Motohide
    Nonomura, Norio
    Rakugi, Hiromi
    CLINICAL CASE REPORTS, 2019, 7 (10): : 1895 - 1899
  • [6] Superselective adrenal arterial embolization for primary aldosteronism without lateralized aldosterone secretion: an efficacy and safety, proof-of-principle study
    Qiu, Jian
    Li, Ning
    Xiong, Hong-Liang
    Yang, Jiao
    Li, Yun-De
    Hu, Chen-Kai
    Lai, Ze-Qun
    Liang, Ning-Peng
    Zhang, Hong-Jin
    Jiang, Xiong-Jing
    Dong, Yi-Fei
    HYPERTENSION RESEARCH, 2023, 46 (05) : 1297 - 1310
  • [7] Role of percutaneous arterial embolization in renal pathology
    Loffroy, R.
    Abualsaud, B.
    Delgal, A.
    Guiu, B.
    Kermarrec, I.
    Michel, F.
    Cormier, L.
    Mousson, C.
    Majbri, N.
    Rebibou, J. -M.
    Cercueil, J. -P.
    Krause, D.
    PROGRES EN UROLOGIE, 2010, 20 (03): : 161 - 171
  • [8] IMPORTANCE OF DEHYDROEPIANDROSTERONE SULFATE ASSESSMENT WITH SPECIAL ATTENTION FOR ADRENAL TUMOURS AND ARTERIAL HYPERTENSION
    Matulevicius, V
    Urbanavicius, V
    Lukosevicius, S.
    Banisauskaite, I
    Donielaite, G.
    Galkine, A.
    ACTA ENDOCRINOLOGICA-BUCHAREST, 2021, 17 (01) : 68 - 76
  • [9] A Need for Improvement in the Definition of Resistant Arterial Hypertension
    Koracevic, Goran
    Micic, Sladjana
    Stojanovic, Milovan
    Zdravkovic, Marija
    MEDICINA-LITHUANIA, 2023, 59 (04):
  • [10] Percutaneous Computer Tomography-Guided Ethanol Sympathicolysis for the Treatment of Resistant Arterial Hypertension
    Streitparth, F.
    Gebauer, B.
    Nickel, P.
    Reinke, P.
    Freyhardt, P.
    Wieners, G.
    Hamm, B.
    Guenther, R. W.
    CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, 2014, 37 (02) : 513 - 518